The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
In rheumatoid arthritis (RA), the high diagnostic value of serum antibodies to the stratum corneum of rat esophagus epithelium has been widely reported.These so-called "antikeratin antibodies," detected by indirect immunofluorescence, were found to be autoantibodies since they also labeled human epidermis.Despite their name, the actual target of these autoanti- bodies was not known.In this study, a 40-kD protein (designated as 40K), extracted from human epidermis and specifically immunodetected by 75% of RA sera, was purified and identified as a neutral/acidic isoform of basic filaggrin, a cytokeratin filament-aggregating protein, by peptide mapping stud- ies and by the following evidences: (a) mAbs specific for filag- grin reacted with the 40K protein; (b) the autoantibodies, affin- ity-purified from RA sera on the 40K protein, immunodetected purified filaggrin; (c) the reactivity of RA sera to the 40K protein was abolished after immunoadsorption with purified filag- grin; (d) the 40K protein and filaggrin had similar amino acid compositions.Furthermore, autoantibodies against the 40K protein and the so-called "antikeratin antibodies" were shown, by immunoadsorption experiments, to be largely the same.The identification of filaggrin as a RA-specific autoantigen could contribute to the understanding of the pathogenesis of this dis- ease and, ultimately, to the development of methods for preventing the autoimmune response.(J.Clin.Invest.1993.92:1387-1393.)Key words: autoimmunity * autoantigen * diag- nosis * intermediate filament-associated protein * epidermis was submitted to SDS-PAGE and electrotransferred to immobilon- PVDF membranes (Millipore Corp., Bedford, MA).The 40K protein Antifilaggrin Autoantibodies Specificfor Rheumatoid Arthritis 1387
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Cleveland, D. W., Fischer, S. G., Kirschner, M. W., & Laemmli, U. K. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75212-0 · Cited by 5,556
Rheumatoid Arthritis: Pathophysiology and Implications for Therapy
Epstein, F. H., & Harris, E. D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221805 · Cited by 1,551
Antinuclear Antibodies: Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology
Tan, E. M. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60641-0 · Cited by 1,514
Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis
Eden, W. V., Tholet, J. E. R., Zee, R. V. D., Noordzij, A., van Embden, J. D. A., Hensen, E. J., & Cohen, I. R. (1988) · Nature · doi:10.1038/331171a0 · Cited by 822
Stress Proteins And Immunology
Young, R. (1990) · Annual Review of Immunology · doi:10.1146/annurev.immunol.8.1.401 · Cited by 461
New Serum Factor in Patients with Rheumatoid Arthritis: The Antiperinuclear Factor
Nienhuis, R. L. F., Mandema, E., & Smids, C. (1964) · Annals of the Rheumatic Diseases · doi:10.1136/ard.23.4.302 · Cited by 367
Anti-keratin antibodies in rheumatoid arthritis.
Young, B. J., Mallya, R. K., Leslie, R. D., Clark, C. J., & Hamblin, T. J. (1979) · BMJ · doi:10.1136/bmj.2.6182.97 · Cited by 336
Steinert, P. M., Cantieri, J. S., Teller, D. C., Lonsdale-Eccles, J. D., & Dale, B. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4097 · Cited by 320
Assembly of stratum corneum basic protein and keratin filaments in macrofibrils
DALE, B. A., HOLBROOK, K. A., & STEINERT, P. M. (1978) · Nature · doi:10.1038/276729a0 · Cited by 283
Cited by
Schellekens, G. A., Visser, H., De Jong, B. A. W., Van Den Hoogen, F. H. J., Hazes, J. M. W., Breedveld, F. C., & Van Venrooij, W. J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<155::aid-anr20>3.0.co;2-3 · Cited by 1,450
Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B., & van Venrooij, W. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1316 · Cited by 1,450
Masson-Bessière, C., Sebbag, M., Girbal-Neuhauser, E., Nogueira, L., Vincent, C., Senshu, T., & Serre, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4177 · Cited by 643
Self-citationHumby, F., Bombardieri, M., Manzo, A., Kelly, S., Blades, M. C., Kirkham, B., Spencer, J., & Pitzalis, C. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.0060001 · Cited by 537
Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis
Kuhn, K. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25422 · Cited by 534
Citrullination: A posttranslational modification in health and disease
György, B., Tóth, E., Tarcsa, E., Falus, A., & Buzás, E. I. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.03.008 · Cited by 500
Girbal-Neuhauser, E., Durieux, J.-J., Arnaud, M., Dalbon, P., Sebbag, M., Vincent, C., Simon, M., Senshu, T., Masson-Bessière, C., Jolivet-Reynaud, C., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.585 · Cited by 485
Self-citationWegner, N., Lundberg, K., Kinloch, A., Fisher, B., Malmström, V., Feldmann, M., & Venables, P. J. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00850.x · Cited by 471
Immunity to Citrullinated Proteins in Rheumatoid Arthritis
Klareskog, L., Rönnelid, J., Lundberg, K., Padyukov, L., & Alfredsson, L. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090244 · Cited by 463
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Vossenaar, E. R., Després, N., Lapointe, E., van der Heijden, A., Lora, M., Senshu, T., van Venrooij, W. J., & Ménard, H. A. (2004) · Arthritis Res Ther · doi:10.1186/ar1149 · Cited by 463
Vossenaar, E. R., Radstake, T. R. D., van der Heijden, A., van Mansum, M. A. M., Dieteren, C., de Rooij, D.-J., Barrera, P., Zendman, A. J. W., & van Venrooij, W. J. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.012211 · Cited by 455
Epithelial Structural Proteins of the Skin and Oral Cavity: Function in Health and Disease
Presland, R. B., & Dale, B. A. (2000) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411000110040101 · Cited by 393
Sebbag, M., Simon, M., Vincent, C., Masson-Bessière, C., Girbal, E., Durieux, J. J., & Serre, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117969 · Cited by 344
Self-citationAnti-CCP antibodies: the past, the present and the future
van Venrooij, W. J., van Beers, J. J. B. C., & Pruijn, G. J. M. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.76 · Cited by 341
Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.
Hammer, J., Gallazzi, F., Bono, E., Karr, R. W., Guenot, J., Valsasnini, P., Nagy, Z. A., & Sinigaglia, F. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1847 · Cited by 307
Diagnostic Accuracy of the Anti-Citrulline Antibody Assay for Rheumatoid Arthritis
Bizzaro, N., Mazzanti, G., Tonutti, E., Villalta, D., & Tozzoli, R. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.6.1089 · Cited by 282
Metadata
- Authors
- Simon, M., Girbal, E., Sebbag, M., Gomès-Daudrix, V, Vincent, C., Salama, G., & Serre, G.
- Venue
- Journal of Clinical Investigation
- Published
- 1993-09-01
- Volume
- 92
- Issue
- 3
- Pages
- 1387-1393
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2006167010
- Cited by
- 262
- References
- 17
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.